VCs and universities struggle with different goals and timelines, but tech transfer is helping turn academic science into ...

Discover eight allergy companies leading the way in 2026, developing allergy therapies that go beyond emergency management.

Phage therapy is emerging as a potential solution to antibiotic resistance and superbugs, with clinical advances in ...

Delve into the pipeline strategy of major biotech Amgen, which is increasingly diversifying its growth engines.

Discover what were the top biotech deals that were signed in March 2026. From small molecules to antibodies, M&A activity was high.

The companies Earendil Labs, Teva Pharmaceuticals, and Solid Biosciences bagged the biggest biotech funding rounds overall in ...

Cell and gene therapies are moving towards correcting root causes of diseases. Let's take a look at future cell and gene therapy trends.

We explore what allosteric modulators are, their benefits and drawbacks, and which candidates are currently advancing through the clinic.

Once a booming field, bustling with innovation and money driving that innovation, the cell and gene therapy sector is now struggling to fuel therapeutic growth to bring medicines to patients. It doesn ...

The excitement surrounding artificial intelligence (AI)’s potential to transform healthcare has led to substantial investments and a proliferation of startups eager to harness the power of machine ...